The overall aim of BlueShell is to explore different aspects of bioactivity in fermented/hydrolysed shellfish by-products which can serve as a basis for new high-value products aiding a sustainable supply of safe, health promoting foods.
|Time:||1. January 2017 – 31. December 2019|
|Financed by:||EU, ERA-Net|
The aim will be reached through the following subgoals:
- Apply enzyme driven hydrolysis and fermentation on shellfish by-products to produce a lipid rich fraction, a protein/peptide rich fraction and a sludge fraction.
- Screen all or selected fractions for bioactivity targeting a diverse plethora of end-points: i) human nutrition, ii) food safety, iii)plant health
- Identify the most active compounds in the fractions emerging under WP2, and study upscale feasibility for their production assess business potential and market analyses with focus on 4 concrete cases
- Manage efficiently the project and the results dissemination